Diffusion magnetic resonance imaging of chest tumors

Cancer Imaging

Volumn 12, Issue 3, 2012, Pages 452-463

  Abdel Razek, Ahmed Abdel Khalek ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Chest; Diffusion; Lung cancer; Lymph node; Mediastinal; MR imaging; Pleura; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE;

CANCER DIAGNOSIS; CANCER PROGNOSIS; CHEMORADIOTHERAPY; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; HISTOGRAM; HUMAN; LUNG CANCER; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MEDIASTINUM TUMOR; PATIENT MONITORING; PLEURA EFFUSION; PLEURA MESOTHELIOMA; PREDICTION; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; THORAX TUMOR; TREATMENT RESPONSE;

DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; REPRODUCIBILITY OF RESULTS; THORACIC NEOPLASMS;

EID: 84870428012     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2012.0041     Document Type: Review

References (50)

1. Katz S, Ferrara T, Alavi A, et al. PET, CT, and MR imaging for assessment of thoracic malignancy: structure meets function. PET Clin 2009; 3: 395-410. doi:10.1016/j.cpet.2009.03.008.
2. Shim SS, Lee KS, Kim BT, et al. Accuracy of integrated PET/CT using fluorodeoxyglucose for the preoperative staging of non-small cell lung cancer: a prospective comparison with standalone CT. Radiology 2005; 236: 1011-1019. doi:10.1148/radiol.2363041310. PMid:16014441.
3. Hochhegger B, Marchiori E, Sedlaczek O, et al. MRI in lung cancer: a pictorial essay. Br J Radiol 2011; 84: 661-668. doi:10.1259/bjr/24661484. PMid:21697415.
4. Bellomi M. Non-conventional imaging of lung cancer. Cancer Imaging 2010; 10: S161-162. doi:10.1102/1470-7330.2010.9035. PMid:20880776.
5. Kauczor HU, Ley S. Thoracic magnetic resonance imaging 1985 to 2010. J Thorac Imaging 2010; 25: 34-38. doi:10.1097/RTI.0b013e3181cc4cd7. PMid:20160600.
6. Rangel C, Cruz L, Jr. Takayassu T, Gasparetto E, Domingues R. Diffusion MR imaging in central nervous system. Magn Reson Imaging Clin North Am 2011; 19: 23-53. doi:10.1016/j.mric.2010.10.006.
7. Malayeri A, El Khouli R, Zaheer A, et al. Principles and applications of diffusion-weighted imaging in cancer detection, staging, and treatment follow-up. Radiographics 2011; 31: 1773-1791. doi:10.1148/rg.316115515.
8. Bonekamp S, Corona-Villalobos C, Kamel I. Oncologic applications of diffusion-weighted MRI in the body. J Magn Reson Imaging 2012; 35: 257-279. doi:10.1002/jmri.22786. PMid:22271274.
9. Abdel Razek A. Diffusion-weighted magnetic resonance imaging of head and neck. J Comput Assist Tomogr 2010; 34: 808-815. doi:10.1097/RCT. 0b013e3181f01796.
10. Abdel Razek A, Gaballa G, Denewer A, Tawakol I. Diffusion weighted MR imaging of the breast. Acad Radiol 2010; 17: 382-386. doi:10.1016/j.acra.2009. 10.014. PMid:20004597.
11. Luna A, Sánchez-Gonzalez J, Caro P. Diffusion-weighted imaging of the chest. Magn Reson Imaging Clin North Am 2011; 19: 69-94. doi:10.1016/j.mric.2010.09.006.
12. Luna A, Martin T, Sánchez-Gonzalez J. Diffusion-weighted imaging in the evaluation of lung, mediastinum, heart, and chest wall. In: Luna A, Ribes R, Soto JA, editors. Diffusion MRI outside the brain. Berlin: Springer-Verlag; 2012, p. 279-316.
13. Henzler T, Schmid-Bindert G, Schoenberg SO, Fink C. Diffusion and perfusion MRI of the lung and mediastinum. Eur J Radiol 2010; 76: 329-336. doi:10.1016/j.ejrad.2010.05.005. PMid:20627435.
14. Regier M, Schwarz D, Henes F, et al. Diffusion-weighted MR-imaging for the detection of pulmonary nodules at 1.5 Tesla: intraindividual comparison with multidetector computed tomography. J Med Imaging Radiat Oncol 2011; 55: 266-274. doi:10.1111/j.1754-9485.2011.02263.x. PMid:21696559.
15. Matoba M, Tonami H, Kondou T, et al. Lung carcinoma: diffusion weighted MR imaging - preliminary evaluation with apparent diffusion coefficient. Radiology 2007; 243: 570-577. doi:10.1148/radiol.2432060131. PMid:17400757.
16. Liu H, Liu Y, Yu T, Ye N. Usefulness of diffusion-weighted MR imaging in the evaluation of pulmonary lesions. Eur Radiol 2010; 20: 807-815. doi:10.1007/s00330-009-1629-6. PMid:19862533.
17. Satoh S, Kitazume Y, Ohdama S, Kimula Y, Taura S, Endo Y. Can malignant and benign pulmonary nodules be differentiated with diffusion-weighted MRI? Am J Roentgenol 2008; 191: 464-470. doi:10.2214/AJR.07.3133.
18. Mori T, Nomori H, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses. Comparison with positron emission tomography. J Thorac Oncol 2008; 3: 358-364. doi:10.1097/JTO.0b013e318168d9ed. PMid:18379353.
19. Uto T, Takehara Y, Nakamura Y, et al. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology 2009; 252: 247-254. doi:10.1148/radiol.2521081195. PMid:19420317.
20. Tondo F, Saponaro A, Stecco A, et al. Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum. Radiol Med 2011; 116: 720-733. doi:10.1007/s11547-011-0629-1. PMid:21293944.
21. Chen W, Jian W, Li H, et al. Whole-body diffusion weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Magn Reson Imaging 2010; 28: 613-620. doi:10.1016/j.mri.2010.02.009. PMid:20418042.
22. Ohba Y, Nomori H, Mori T, et al. Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer? J Thorac Cardiovasc Surg 2009; 138: 439-445. doi:10.1016/j.jtcvs.2008.12.026. PMid:19619793.
23. Tanaka R, Horikoshi H, Nakazato Y, et al. Magnetic resonance imaging in peripheral lung adenocarcinoma: correlation with histopathologic features. J Thorac Imaging 2009; 24: 4-9. doi:10.1097/RTI.0b013e31818703b7. PMid:19242296.
24. Koyama H, Ohno Y, Aoyama N, et al. Comparison of STIR turbo SE imaging and diffusion-weighted imaging of the lung: capability for detection and subtype classification of pulmonary adenocarcinomas. Eur Radiol 2010; 20: 790-800. doi:10.1007/s00330-009-1615-z. PMid:19763578.
25. Kanauchi N, Oizumi H, Honma T, et al. Role of diffusion-weighted magnetic resonance imaging for predicting of tumor invasiveness for clinical stage IA non-small cell lung cancer. Eur J Cardiothorac Surg 2009; 35: 706-711. doi:10.1016/j.ejcts.2008.12.039. PMid:19216085.
26. Abdel Razek A, Fathy A, Abdel Gawad T. Correlation of apparent diffusion coefficient value with prognostic parameters of lung cancer. J Comput Assist Tomogr 2011; 35: 248-252. doi:10.1097/RCT.0b013e31820ccf73.
27. Regier M, Derlin T, Schwarz D, et al. Diffusion weighted MRI and 18F-FDG PET/CT in non-small cell lung cancer (NSCLC): Does the apparent diffusion coefficient (ADC) correlate with tracer uptake (SUV)? Eur J Radiol 2012; 81: 2913-2918. doi:10.1016/j.ejrad.2011.11.050. PMid:22197090.
28. Baysal T, Mutlu D, Yologlu S. Diffusion-weighted magnetic resonance imaging in differentiation of postobstructive consolidation from central lung carcinoma. Magn Reson Imaging 2009; 27: 1447-1454. doi:10.1016/j.mri.2009.05. 024. PMid:19553048.
29. Qi L, Zhang X, Tang L, et al. Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study. Eur Radiol 2009; 19: 333-341. doi:10.1007/s00330-008-1134-3. PMid:18690450.
30. Nomori H, Mori T, Ikeda K, et al. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg 2008; 135: 816-822. doi:10.1016/j.jtcvs.2007.10.035. PMid:18374761.
31. Hasegawa I, Boiselle P, Kuwabara K, Sawafuji M, Sugiura H. Mediastinal lymph nodes in patients with non-small cell lung cancer: preliminary experience with diffusion-weighted MR imaging. J Thorac Imaging 2008; 23: 157-161. doi:10.1097/RTI.0b013e318166d2f5. PMid:18728541.
32. Nakayama J, Miyasaka K, Omatsu T, et al. Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient. J Comput Assist Tomogr 2010; 34: 1-8. doi:10.1097/RCT.0b013e3181a9cc07. PMid:20118713.
33. 18F]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol 2012; 81: 178-182. doi:10.1016/j.ejrad.2010.09. 001. PMid:20932700.
34. Ohno Y, Koyama H, Yoshikawa T, et al. N stage disease in patients with non-small cell lung cancer: efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. Radiology 2011; 261: 605-615. doi:10.1148/radiol. 11110281. PMid:21926377.
35. Ohno Y, Koyama H, Onishi Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment-utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology 2008; 248: 643-654. doi:10.1148/radiol.2482072039. PMid:18539889.
36. Takenaka D, Ohno Y, Matsumoto K, et al. Detection of bone metastases in non-small cell lung cancer patients: comparison of whole-body diffusion-weighted imaging (DWI), whole-body MR imaging without and with DWI, whole-body FDGPET/CT, and bone scintigraphy. J Magn Reson Imaging 2009; 30: 298-308. doi:10.1002/jmri.21858. PMid:19629984.
37. Okuma T, Matsuoka T, Yamamoto A, et al. Assessment of early treatment response after CT-guided radiofrequency ablation of unresectable lung tumours by diffusion-weighted MRI: a pilot study. Br J Radiol 2009; 82: 989-994. doi:10.1259/bjr/13217618. PMid:19470575.
38. Yabuuchi H, Hatakenaka M, Takayama K, et al. Non-small cell lung cancer: detection of early response to chemotherapy by using contrast-enhanced dynamic and diffusion-weighted MR imaging. Radiology 2011; 261: 598-604. doi:10.1148/radiol.11101503. PMid:21852569.
39. 18F-FDG PET/CT: performance as predictors of tumor treatment response and patient survival in patients with non-small cell lung cancer receiving chemoradiotherapy. Am J Roentgenol 2012; 198: 75-82. doi:10.2214/AJR.11.6525.
40. Abdel Razek A, Elmorsy A, Elshafey M, Elhadedy T, Hamza O. Assessment of mediastinal tumors with diffusion weighted single shot echo planar MR imaging. J Magn Reson Imaging 2009; 30: 535-540. doi:10.1002/jmri.21871.
41. Gümüştaş S, -Inan N, Sarisoy H, et al. Malignant versus benign mediastinal lesions: quantitative assessment with diffusion weighted MR imaging. Eur Radiol 2011; 21: 2255-2260.
42. Abdel Razek A, Soliman N, Elashery R. Apparent diffusion coefficient values of mediastinal masses in children. Eur J Radiol 2012; 81: 1311-1314. doi:10.1016/j.ejrad.2011.03.008. PMid:21439745.
43. Kosucu P, Tekinbas C, Erol M, et al. Mediastinal lymph nodes: assessment with diffusion-weighted MR imaging. J Magn Reson Imaging 2009; 30: 292-297. doi:10.1002/jmri.21850. PMid:19629990.
44. Abdel Razek A, Elkammary S, Elmorsy A, et al. Characterization of mediastinal lymphadenopathy with diffusion-weighted imaging. Magn Reson Imaging 2011; 29: 167-172. doi:10.1016/j.mri.2010.08.002. PMid:20951522.
45. Gill R, Umeoka S, Mamata H, et al. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. Am J Roentegonl 2010; 195: W125-130. doi:10.2214/AJR.09.3519.
46. Baysal T, Bulut T, G€okirmak M, Kalkan S, Dusak A, Dogan M. Diffusion-weighted MR imaging of pleural fluid: differentiation of transudative vs exudative pleural effusions. Eur Radiol 2004; 14: 890-896. PMid:12904883.
47. Inan N, Arslan A, Akansel G, et al. Diffusion weighted MRI in the characterization of pleural effusions. Diagn Interv Radiol 2009; 15: 13-18. PMid:19263368.
48. Coolen J, De Keyzer F, Nafteux P, et al. Malignant pleural disease: diagnosis by using diffusion-weighted and dynamic contrast-enhanced MR imaging - initial experience. Radiology 2012; 263: 884-892. doi:10.1148/radiol.12110872. PMid:22535562.
49. Abdel Razek A, Megahed A, Motamed A, Tawfik A, Nada N. Role of diffusion weighted MR imaging in differentiation between viable and necrotic part of head and neck tumors. Acta Radiol 2008; 49: 364-370. doi:10.1080/02841850701777390.
50. Schafer J, Srinivasan A, Mukherji S. Diffusion magnetic resonance imaging in the head and neck. Magn Reson Imaging Clin North Am 2011; 19: 55-67. doi:10.1016/j.mric.2010.10.002.